Comparison of serum neurodegenerative biomarkers among hospitalized COVID‐19 patients versus non‐COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia

INTRODUCTION: Neurological complications among hospitalized COVID‐19 patients may be associated with elevated neurodegenerative biomarkers. METHODS: Among hospitalized COVID‐19 patients without a history of dementia (N = 251), we compared serum total tau (t‐tau), phosphorylated tau‐181 (p‐tau181), g...

Descripción completa

Detalles Bibliográficos
Autores principales: Frontera, Jennifer A., Boutajangout, Allal, Masurkar, Arjun V., Betensky, Rebecca A., Ge, Yulin, Vedvyas, Alok, Debure, Ludovic, Moreira, Andre, Lewis, Ariane, Huang, Joshua, Thawani, Sujata, Balcer, Laura, Galetta, Steven, Wisniewski, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Featured Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011610/
https://www.ncbi.nlm.nih.gov/pubmed/35023610
http://dx.doi.org/10.1002/alz.12556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011610/
https://www.ncbi.nlm.nih.gov/pubmed/35023610
http://dx.doi.org/10.1002/alz.12556

Ejemplares similares